GRRMF (Gerresheimer AG) Stock Based Compensation: $0 Mil (TTM As of Nov. 2025)


GRRMF Gerresheimer AG GRRMF
58 GF Score
Price $33.35
GF Value $189.88
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Gerresheimer AG Stock Based Compensation?

Gerresheimer AG GRRMF 58 Stock Based Compensation is $0 Mil as of Nov. 2025. GuruFocus rates GRRMF with a GF Score™ of 58/100 and a GF Value™ of $189.88 (Possible Value Trap). The stock has 6 warning signs investors should review.

Gerresheimer AG's Stock Based Compensation for the three months ended in Nov. 2025 was $0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Nov. 2025 was $0 Mil.

Gerresheimer AG Stock Based Compensation Related Terms

Gerresheimer AG Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Gerresheimer AG's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG Stock Based Compensation Chart

Gerresheimer AG Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Gerresheimer AG Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
GRRMF
58GF Score
Gerresheimer AG GRRMF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gerresheimer AG Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

What does a Stock Based Compensation of $0 Mil mean?
Gerresheimer AG (GRRMF) has a Stock Based Compensation of $0 Mil as of Nov. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Gerresheimer AG and its competitors.
Is Gerresheimer AG's Stock Based Compensation too high?
Gerresheimer AG's current Stock Based Compensation is $0 Mil. Overall, Gerresheimer AG has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Stock Based Compensation compare to ISRG and BDX?
Gerresheimer AG's Stock Based Compensation of $0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Gerresheimer AG and its competitors. Gerresheimer AG's current Stock Based Compensation is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $189.88, compared to a current price of $33.35 — trading 82.4% below its estimated fair value. The current Stock Based Compensation is $0 Mil. Gerresheimer AG's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current Stock Based Compensation is $0 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gerresheimer AG (GRRMF) Overvalued in 2026?

Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued. The current stock price of $33.35 is trading 82.4% below its estimated GF Value™ of $189.88. GuruFocus considers Gerresheimer AG to be Possible Value Trap.

Key valuation signals for GRRMF:

  • Stock Based Compensation: $0 Mil
  • GF Value™: $189.88 vs. price of $33.35 (82.4% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gerresheimer AG Business Description

Address Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
58GF Score

Get the complete analysis for GRRMF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.35
Price
$189.88
GF Value